HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Serum metabolome alterations in patients with early nonalcoholic fatty liver disease.

AbstractBACKGROUND:
Although metabolomic analysis for patients with nonalcoholic fatty liver disease (NAFLD) was a promising approach to identify novel biomarkers as targets for the diagnosis of NAFLD, the serum metabolomics profile of early-stage NAFLD patients from central China remain unknown.
OBJECTIVE:
The aim of the present study was to explore the metabolic characteristics of patients with early-stage NAFLD based on the ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) technology, to identify differential metabolites and perform functional analysis, and especially, to establish a novel early NAFLD clinical diagnostic tool.
RESULTS:
Compared with healthy controls, serum metabolite species increased significantly in early stage NAFLD patients. Expression of 88 metabolites including 1-naphthylmethanol, rosavin, and theophylline were up-regulated in early NAFLD, while 68 metabolites including 2-hydroxyphenylacetic acid and lysophosphatidylcholine (24:1(15Z)) were down-regulated. The early NAFLD classifier achieved a strong diagnostic efficiency in the discovery phases (80.99%) and was successfully verified in the validation phases (75.23%).
CONCLUSIONS:
These results advance our understanding about the composition and biological functions of serum metabolites of early NAFLD. In addition, serum metabolic markers can serve as an efficient diagnostic tool for the early-stage NAFLD.
AuthorsXuemei Wang, Benchen Rao, Haiyu Wang, Chao Liu, Zhigang Ren, Zujiang Yu
JournalBioscience reports (Biosci Rep) Vol. 42 Issue 10 (10 28 2022) ISSN: 1573-4935 [Electronic] England
PMID36124945 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2022 The Author(s).
Chemical References
  • Lysophosphatidylcholines
  • Theophylline
  • Biomarkers
Topics
  • Humans
  • Non-alcoholic Fatty Liver Disease
  • Chromatography, Liquid
  • Lysophosphatidylcholines
  • Theophylline
  • Tandem Mass Spectrometry
  • Metabolome
  • Metabolomics (methods)
  • Biomarkers

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: